View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Daratumumab 1800 / Lenalidomide 10, multiple myeloma, maintenance after Stem Cell Transplantation, Autologous, Cycle 1-2
Protocol-ID: 2796 V1.0 (Mini), DRTM1800/LENA10, MM, maint. after ASCT, C1-2Indication(s)
- Multiple Myeloma; ICD-10 C90.-, C90.0-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 26.01.2025